^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    GNOS-PV01

    i
    Associations
    News

    Trials

    Company:
    Geneos Therap
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma (NCT04015700)
    Phase 1
    Washington University School of Medicine
    Active, not recruiting
    Last update posted :
    03/08/2024
    Initiation :
    07/14/2020
    Primary completion :
    05/13/2022
    Completion :
    12/31/2024
    IDH1 • IDH2 • MGMT
    |
    IDH2 mutation
    |
    rocakinogene sifuplasmid (INO-9012) • GNOS-PV01 • neoantigen DNA vaccine